CI:NYE-Cigna Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 330.19

Change

0.00 (0.00)%

Market Cap

USD 35.85B

Volume

1.73M

Analyst Target

USD 242.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Cigna Corp is a health services organization. The Company provides medical, dental, disability, life and accident insurance and related products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-12.41 (-2.07%)

USD 446.97B
ELV Elevance Health Inc

+1.36 (+0.31%)

USD 99.57B
CNC Centene Corp

-0.85 (-1.33%)

USD 28.86B
MOH Molina Healthcare Inc

+3.57 (+1.03%)

USD 17.11B
OSCR Oscar Health Inc

-0.15 (-1.19%)

USD 3.26B
NEUE NeueHealth Inc

+0.53 (+8.66%)

USD 0.05B
CVS CVS Health Corp

-0.31 (-0.45%)

N/A
HUM Humana Inc

-10.22 (-3.46%)

N/A

ETFs Containing CI

BOUT Innovator ETFs Trust - In.. 5.98 % 0.80 %

+0.48 (+0.97%)

USD 0.01B
FHI-B:CA CI Health Care Giants Cov.. 5.31 % 0.00 %

N/A

CAD 0.05B
FHI:CA CI Health Care Giants Cov.. 5.16 % 0.75 %

+0.10 (+0.97%)

CAD 0.10B
AILV 4.45 % 0.00 %

N/A

N/A
SHRY First Trust Bloomberg Sha.. 4.14 % 0.00 %

+0.38 (+0.97%)

USD 0.02B
MDPL Northern Lights Fund Trus.. 3.55 % 0.00 %

+0.24 (+0.97%)

USD 0.06B
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
BUSA 2023 EFT Series Trust - B.. 2.80 % 0.00 %

+0.33 (+0.97%)

USD 0.21B
FXH First Trust Health Care A.. 2.22 % 0.63 %

+1.19 (+0.97%)

USD 0.89B
JAVA JPMorgan Active Value ETF 1.65 % 0.00 %

+0.70 (+0.97%)

USD 3.01B
DSTL Distillate US Fundamental.. 1.65 % 0.00 %

+0.37 (+0.97%)

USD 1.79B
FFND The Future Fund Active ET.. 1.62 % 0.00 %

+0.25 (+0.97%)

USD 0.06B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

-1.05 (0.97%)

N/A
IQSE:F Invesco Quantitative Stra.. 1.53 % 0.00 %

+1.64 (+0.97%)

N/A
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

+0.20 (+0.97%)

N/A
FLDZ Listed Funds Trust 0.48 % 0.00 %

+0.33 (+0.97%)

USD 3.65M
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.05 (0.97%)

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

+1.58 (+0.97%)

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.48 (+0.97%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

+3.22 (+0.97%)

N/A
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.77 (+0.97%)

USD 9.23M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+3.26 (+0.97%)

USD 0.26B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+12.88 (+0.97%)

USD 0.21B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.14 (+0.97%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.14 (+0.97%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.25 (+0.97%)

N/A
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+12.17 (+0.97%)

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

+0.17 (+0.97%)

N/A
NTZG 0.00 % 0.00 %

N/A

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

+1.45 (+0.97%)

N/A
IFSW:SW iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.31 (+0.97%)

USD 0.60B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.57% 89% A- 97% N/A
Dividend Return 0.55% 80% B- 28% F
Total Return 20.12% 89% A- 97% N/A
Trailing 12 Months  
Capital Gain -5.62% 56% F 38% F
Dividend Return 1.63% 60% D- 32% F
Total Return -3.98% 67% D+ 34% F
Trailing 5 Years  
Capital Gain 86.04% 67% D+ 73% C
Dividend Return 11.56% 50% F 27% F
Total Return 97.60% 67% D+ 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.05% 78% C+ 72% C
Dividend Return 13.69% 78% C+ 71% C-
Total Return 1.64% 80% B- 39% F
Risk Return Profile  
Volatility (Standard Deviation) 22.63% 67% D+ 46% F
Risk Adjusted Return 60.50% 100% F 74% C
Market Capitalization 35.85B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:

There is nothing we particularly dislike